<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0006785'>Limb-girdle muscular dystrophy</z:hpo> type 2B (LGMD2B) and Miyoshi <z:hpo ids='HP_0003198'>myopathy</z:hpo> (MM) are <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> disorders caused by mutations in the dysferlin gene on chromosome 2p13 </plain></SENT>
<SENT sid="1" pm="."><plain>The authors studied a large Russian family with both LGMD2B and MM </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> affected individuals, as well as one preclinical boy with dystrophic changes on muscle biopsy, were found to be homozygous for a novel dysferlin mutation, TG573/574AT (Val67Asp) </plain></SENT>
<SENT sid="3" pm="."><plain>This finding supports the view that additional factors (e.g., modifier genes) contribute to the phenotypic expression of causative mutations in dysferlinopathies </plain></SENT>
</text></document>